Search Results for “Orbimed” – Endpoints News

SIGN UP

search results for: Orbimed

Takeda’s new deal with Kumquat; IL-2 biotech raises $55M

Last week

Foreign investors fled Chinese biotech after the pandemic. They still haven’t come back

3 weeks ago

Alterome raises $132M to take next-gen cancer drugs aimed at the 'undruggable' into clinic

4 weeks ago

Genmab fuels ADCs' hot streak with $1.8B buyout of ProfoundBio

4 weeks ago

Zymeworks removes CFO; Gilead extends Nurix deal

4 weeks ago

Disc Medicine blames 'outsized' placebo response on mixed Phase 2 data in rare blood disorder

4 weeks ago

Bayer to cut 90 workers; Avalo's up to $185M private placement

4 weeks ago

Exclusive: Athena Countouriotis' Avenzo nabs $150M to in-license more assets

5 weeks ago

Former Prometheus execs raise $400M for precision immunology startup: 'The band is back together'

Last month

'Cell therapy without cells': Capstan raises $175M to test in vivo CAR-T

Last month

Bluebird's $175M loan; Spyre reveals second private placement

Last month

Female investors track progress, call for more women on boards and in leadership roles

Last month

German ADC biotech Tubulis raises $138M to enter the clinic and expand in US

Last month

Ex-Theseus execs extend GIST mission by taking helm of IDRx

Last month

Sionna raises $182M for cystic fibrosis drugs different from Vertex's approach

Last month

BlossomHill raises $100M in bid to repeat founders' cancer success at Turning Point

Last month

Sofinnova’s Maha Katabi on recent M&A and IPO success and how deal flow has ‘never been any better’

2 months ago

BioAge raises $170M as obesity spotlight shifts to oral options, muscle preservers

2 months ago

12 3 4 Next page Last page

latest

Most read

GSK accuses Pfizer and BioNTech of mRNA patent infringement

11 hours ago

Gilead leans on CymaBay liver drug, Trodelvy readouts and long-active PrEP yet to come this year

7 hours ago

In rare move, Colombia issues compulsory license for HIV medicine in effort to expand access

10 hours ago

Esteve to acquire Perrigo's rare disease pharma business for up to $295M

10 hours ago

FDA revises guidance on biosimilar promotional labels and advertising

11 hours ago

see latest stream